Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia.

Flowers SA, Baxter NT, Ward KM, Kraal AZ, McInnis MG, Schmidt TM, Ellingrod VL.

Pharmacotherapy. 2019 Feb;39(2):161-170. doi: 10.1002/phar.2214. Epub 2019 Feb 3.

PMID:
30620405
2.

Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort.

Flowers SA, Evans SJ, Ward KM, McInnis MG, Ellingrod VL.

Pharmacotherapy. 2017 Mar;37(3):261-267. doi: 10.1002/phar.1890. Epub 2017 Feb 20.

3.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

4.

Resistant Starch Alters the Microbiota-Gut Brain Axis: Implications for Dietary Modulation of Behavior.

Lyte M, Chapel A, Lyte JM, Ai Y, Proctor A, Jane JL, Phillips GJ.

PLoS One. 2016 Jan 8;11(1):e0146406. doi: 10.1371/journal.pone.0146406. eCollection 2016.

5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
6.

Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome.

Maier TV, Lucio M, Lee LH, VerBerkmoes NC, Brislawn CJ, Bernhardt J, Lamendella R, McDermott JE, Bergeron N, Heinzmann SS, Morton JT, González A, Ackermann G, Knight R, Riedel K, Krauss RM, Schmitt-Kopplin P, Jansson JK.

MBio. 2017 Oct 17;8(5). pii: e01343-17. doi: 10.1128/mBio.01343-17.

7.

Variable responses of human microbiomes to dietary supplementation with resistant starch.

Venkataraman A, Sieber JR, Schmidt AW, Waldron C, Theis KR, Schmidt TM.

Microbiome. 2016 Jun 29;4(1):33. doi: 10.1186/s40168-016-0178-x.

8.

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.

9.

Resistant starch diet induces change in the swine microbiome and a predominance of beneficial bacterial populations.

Umu ÖC, Frank JA, Fangel JU, Oostindjer M, da Silva CS, Bolhuis EJ, Bosch G, Willats WG, Pope PB, Diep DB.

Microbiome. 2015 Apr 16;3:16. doi: 10.1186/s40168-015-0078-5. eCollection 2015.

11.

Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum.

Crusell MKW, Hansen TH, Nielsen T, Allin KH, Rühlemann MC, Damm P, Vestergaard H, Rørbye C, Jørgensen NR, Christiansen OB, Heinsen FA, Franke A, Hansen T, Lauenborg J, Pedersen O.

Microbiome. 2018 May 15;6(1):89. doi: 10.1186/s40168-018-0472-x.

12.

A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults.

Alfa MJ, Strang D, Tappia PS, Graham M, Van Domselaar G, Forbes JD, Laminman V, Olson N, DeGagne P, Bray D, Murray BL, Dufault B, Lix LM.

Clin Nutr. 2018 Jun;37(3):797-807. doi: 10.1016/j.clnu.2017.03.025. Epub 2017 Mar 31.

13.

Prebiotic supplementation in frail older people affects specific gut microbiota taxa but not global diversity.

Tran TTT, Cousin FJ, Lynch DB, Menon R, Brulc J, Brown JR, O'Herlihy E, Butto LF, Power K, Jeffery IB, O'Connor EM, O'Toole PW.

Microbiome. 2019 Mar 13;7(1):39. doi: 10.1186/s40168-019-0654-1.

14.

The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: comparison with other drug treatments, drug-free psychiatric patients, first-degree relatives and the general population in Venezuela.

Baptista T, Serrano A, Uzcátegui E, ElFakih Y, Rangel N, Carrizo E, Fernández V, Connell L, de Baptista EA, Quiroz S, Uzcátegui M, Rondón J, Matos Y, Uzcátegui L, Gómez R, Valery L, Novoa-Montero D.

Schizophr Res. 2011 Mar;126(1-3):93-102. doi: 10.1016/j.schres.2010.10.014. Epub 2010 Nov 10.

PMID:
21071179
15.

Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study.

Hald S, Schioldan AG, Moore ME, Dige A, Lærke HN, Agnholt J, Bach Knudsen KE, Hermansen K, Marco ML, Gregersen S, Dahlerup JF.

PLoS One. 2016 Jul 19;11(7):e0159223. doi: 10.1371/journal.pone.0159223. eCollection 2016.

16.

Atypical Antipsychotic Administration in Schizophrenic Patients Leads to Elevated Lipoprotein-Associated Phospholipase A2 Levels and Increased Cardiovascular Risk: A Retrospective Cohort Study.

Shen H, Wu D, Wang S, Zhao M, Sun W, Zhu X, Zhang N, Yao H, Cui Q, Xiao H.

Basic Clin Pharmacol Toxicol. 2018 Dec;123(6):756-765. doi: 10.1111/bcpt.13079. Epub 2018 Jul 31.

PMID:
29938908
17.

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins AE, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

Arch Gen Psychiatry. 2005 Jan;62(1):19-28. Erratum in: JAMA Psychiatry. 2017 Jul 1;74(7):764.

PMID:
15630069
18.

Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.

Edwards SJ, Hamilton V, Nherera L, Trevor N.

Health Technol Assess. 2013 Nov;17(54):1-190. doi: 10.3310/hta17540. Review.

19.

A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder.

Chengappa KN, Turkin SR, Schlicht PJ, Murphy SL, Brar JS, Fagiolini A, Houck PR, Garbutt RG, Fredrick N.

Acta Neuropsychiatr. 2010 Apr;22(2):68-80. doi: 10.1111/j.1601-5215.2010.00458.x.

PMID:
25385032
20.

Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects.

Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J.

PLoS One. 2010 Nov 29;5(11):e15046. doi: 10.1371/journal.pone.0015046.

Supplemental Content

Support Center